These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18489910)

  • 1. Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice.
    Pedersen TX; Bro S; Andersen MH; Etzerodt M; Jauhiainen M; Moestrup S; Nielsen LB
    Atherosclerosis; 2009 Feb; 202(2):372-81. PubMed ID: 18489910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
    Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
    Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
    Bro S
    Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin: cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells.
    Ohnsorg PM; Mary JL; Rohrer L; Pech M; Fingerle J; von Eckardstein A
    Biochim Biophys Acta; 2011 Dec; 1811(12):1115-23. PubMed ID: 21930241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
    Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
    Bro S; Binder CJ; Witztum JL; Olgaard K; Nielsen LB
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization.
    Shah PK; Yano J; Reyes O; Chyu KY; Kaul S; Bisgaier CL; Drake S; Cercek B
    Circulation; 2001 Jun; 103(25):3047-50. PubMed ID: 11425766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
    Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
    J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human apolipoprotein A-I exerts a prophylactic effect on high-fat diet-induced atherosclerosis via inflammation inhibition in a rabbit model.
    Li J; Wang W; Han L; Feng M; Lu H; Yang L; Hu X; Shi S; Jiang S; Wang Q; Ye L
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):149-158. PubMed ID: 28069582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of uremia on HDL composition, vascular inflammation, and atherosclerosis in wild-type mice.
    Bang CA; Bro S; Bartels ED; Pedersen TX; Nielsen LB
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1325-31. PubMed ID: 17686960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice.
    Ohta H; Wada H; Niwa T; Kirii H; Iwamoto N; Fujii H; Saito K; Sekikawa K; Seishima M
    Atherosclerosis; 2005 May; 180(1):11-7. PubMed ID: 15823270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dealcoholised beers reduce atherosclerosis and expression of adhesion molecules in apoE-deficient mice.
    Martinez N; Urpi-Sarda M; Martinez-Gonzalez MA; Andres-Lacueva C; Mitjavila MT
    Br J Nutr; 2011 Mar; 105(5):721-30. PubMed ID: 21134332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.
    Hewing B; Parathath S; Barrett T; Chung WK; Astudillo YM; Hamada T; Ramkhelawon B; Tallant TC; Yusufishaq MS; Didonato JA; Huang Y; Buffa J; Berisha SZ; Smith JD; Hazen SL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):779-89. PubMed ID: 24407029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice.
    Preusch MR; Bea F; Yang SH; Kreuzer J; Isermann B; Pedal I; Rosenfeld ME; Katus HA; Blessing E
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Jawien J; Csanyi G; Gajda M; Mateuszuk L; Lomnicka M; Korbut R; Chlopicki S
    Eur J Pharmacol; 2007 Feb; 556(1-3):129-35. PubMed ID: 17174298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiatherogenic effect of antioxidant polyphenols from Phellinus baumii in apolipoprotein E-deficient mice.
    Noh JR; Lee IK; Kim YH; Gang GT; Hwang JH; Ly SY; Yun BS; Lee CH
    Ann Nutr Metab; 2011; 59(2-4):145-53. PubMed ID: 22142871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice.
    Bro S; Borup R; Andersen CB; Moeller F; Olgaard K; Nielsen LB
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):570-5. PubMed ID: 16373611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
    Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
    Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice.
    Bro S; Moeller F; Andersen CB; Olgaard K; Nielsen LB
    J Am Soc Nephrol; 2004 Jun; 15(6):1495-503. PubMed ID: 15153560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.